Literature DB >> 32389365

Hepatitis E: Epidemiology, Clinical Course, Prevention, and Treatment.

Amit Goel1, Rakesh Aggarwal2.   

Abstract

Hepatitis E virus is a common cause of acute hepatitis and acute liver failure in resource-constrained parts of the world. The disease is particularly severe when the infection occurs during pregnancy. In developed countries, human infections occur primarily through zoonotic transmission from animal reservoirs; however, clinical disease is less frequent than in the developing world. The virus strains prevalent in these areas also cause chronic infection in immunocompromised persons, which, if untreated, can progress to cirrhosis; such infection responds well to oral ribavirin. A safe and highly effective recombinant vaccine is available in China, but is not available elsewhere.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis E; Prevention; Transmission; Vaccination

Year:  2020        PMID: 32389365     DOI: 10.1016/j.gtc.2020.01.011

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  8 in total

1.  [Viral hepatitis A-E].

Authors:  Annegrit Decker; Christoph Neumann-Haefelin; Robert Thimme
Journal:  Internist (Berl)       Date:  2021-02       Impact factor: 0.743

2.  Hepatitis E in a Portuguese cohort of human immunodeficiency virus positive patients: High seroprevalence but no chronic infections.

Authors:  Rita Filipe; Beatriz Prista-Leão; André Silva-Pinto; Isabel Abreu; Rosário Serrão; Rosário Costa; Edite Guedes; Joana Sobrinho-Simões; António Sarmento; Carmo Koch; Lurdes Santos
Journal:  Health Sci Rep       Date:  2022-05-20

Review 3.  Hepatitis E in immunocompromised individuals.

Authors:  Konstantinos Damiris; Mohamad Aghaie Meybodi; Mumtaz Niazi; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2022-03-27

4.  Hepatitis A and E among immigrants and refugees in Central Brazil.

Authors:  Grazielle Rosa da Costa E Silva; Thaynara Lorrane Silva Martins; Carla de Almeida Silva; Karlla Antonieta Amorim Caetano; Megmar Aparecida Dos Santos Carneiro; Bruno Vinicius Diniz E Silva; Leonora Rezende Pacheco; Livia Melo Villar; Vanessa Salete de Paula; Regina Maria Bringel Martins; Sheila Araújo Teles
Journal:  Rev Saude Publica       Date:  2022-04-22       Impact factor: 2.772

Review 5.  Towards the Improved Accuracy of Hepatitis E Diagnosis in Vulnerable and Target Groups: A Global Perspective on the Current State of Knowledge and the Implications for Practice.

Authors:  Jasminka Talapko; Tomislav Meštrović; Emina Pustijanac; Ivana Škrlec
Journal:  Healthcare (Basel)       Date:  2021-01-29

Review 6.  Transfusion-transmitted hepatitis E: What we know so far?

Authors:  Carmen Ka Man Cheung; Sunny Hei Wong; Alvin Wing Hin Law; Man Fai Law
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

Review 7.  Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 11.413

8.  Predicting incidence of hepatitis E using machine learning in Jiangsu Province, China.

Authors:  Xiaoqing Cheng; Wendong Liu; Xuefeng Zhang; Minghao Wang; Changjun Bao; Tianxing Wu
Journal:  Epidemiol Infect       Date:  2022-07-28       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.